Meanwhile, two-dimensional gel electrophoresis and mass spectrometry analyses indicated that ALDH6A1 was highly specific to metastatic tumor cells and its expression was significantly reduced in metastatic prostate cancer [31]. This evidence concerns the gene ALDH6A1 and metastatic prostate carcinoma.